The Leukemia & Lymphoma Society Named to Fast Company's Second Annual "Brands That Matter" List

The Leukemia & Lymphoma Society Named to Fast Company’s Second Annual “Brands That Matter” List

Recognition program honors businesses and nonprofits by providing compelling reasons for people to care and inspiring others to join

RYE BROOK, NY, October 25, 2022 /PRNewswire/ — fast business today announced its second annual Brands That Matter list, honoring brands that communicate and demonstrate brand purpose. These businesses and nonprofits became relevant through their cultural impact and social engagement, and authentically communicated their missions and ideals.

The final list, which includes large multinational conglomerates, small but mighty companies and nonprofits, recognizes 145 brands that give people compelling reasons to care and inspire others to join. All 145 have found an ability to forge an emotional connection with customers, whether it’s leading the environment or pop culture, engaging B2B customers or responding meaningfully to current events.

All brands that applied were considered for overall recognition. Additionally, there are also winners on category-specific lists based on region, size, and status.

“This year, we expanded the Brands That Matter program to assess winners in the context of their importance in the category in which they compete for people’s attention or loyalty. The result is an expanded list of winners who make their mark on culture, and through social impact,” said Brendan Vaughan, fast business‘s editor.

The Leukemia & Lymphoma Society (LLS) relentlessly innovates to meet the needs of an ever-changing world, while advancing its mission to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and to improve the quality of life of patients and their families. When patients across the country faced increased hardship and struggled to receive critical medical care, LLS went over-deployed to meet the needs of the blood cancer community, including:

  • Activation of the National LLS Patient Registry, a project of the Michael J. Garil Patient Data Collective, which has collected the largest dataset to date (12,000 patients) on vaccine safety and effectiveness for all major types of blood cancer and treatment. The registry has informed national public health policy, including the CDC’s approval of a third COVID-19 booster for immunocompromised patients.
  • Connecting people in times of growing isolation – reaching 23% more with online support groups and connecting 31% more blood cancer patients with life-saving clinical trials.
  • Expand clinical trials to underserved community hospitals and clinics in urban, rural and low-income communities.
  • Galvanize the management of pediatric cancer, a field lacking in innovation for 50 years, by putting $175 million towards transforming the treatment of children with blood cancer with the Dare to Dream project.
  • Providing relief to those affected by Hurricanes Fiona and Ian through the LLS Financial Relief Fund.

Through it all, LLS exceeded its targets by 23%, increasing $168 million through Light The Night, Team In Training, Visionaries of the Year and other in-person events, to fund more research and service than ever before.

“It is an honor to be recognized as the only cancer service organization and the only health care organization in the non-profit category. This is an important time to recognize that our success depends on so many others. We are not the authors of our innovation, but we manage it with the power we have as unifiers,” said Troy Dunmire, Chief Operating Officer of the Leukemia & Lymphoma Society of Canada. “It’s everyone we collaborate with – patients, philanthropists, partners, volunteers, researchers and healthcare providers – who make our mission possible.”

Every action counts and there are many ways to support the mission of LLS: donate on to advance research and help more patients and families, become an advocate for better health policies, participate in the one of the many volunteer opportunities or follow on social media (@LLSusa).

fast business editors judged each brand on relevance, cultural impact, ingenuity, and business impact to compile the list.

Click here to see the full list.

The November issue of fast business magazine is available online now and will be on newsstands from November 1, 2022.

About Fast Company

Fast Company is the only media brand entirely dedicated to the vital intersection of business, innovation and design, engaging the most influential leaders, companies and thinkers on the future of business. The editor is Brendan Vaughan. Based at New York City, fast business is published by Mansueto Ventures LLC, along with our sister publication, Inc.and can be viewed online at

About the Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society® (LLS) is the world leader in the fight against blood cancer. The mission of the LLS: To cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and to improve the quality of life of patients and their families. The LLS funds vital blood cancer research worldwide, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality coordinated care. , affordable.

Founded in 1949 and based in Rye Creek, NYLLS has regions across United States and Canada. To learn more, visit Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.

LLS is one of Fast Company’s 2022 Brands That Matter. One of only nine nonprofits, LLS stands out among brands around the world for its relevance, cultural impact, ingenuity, and mission impact.

For more information, visit Follow us on Facebook, Twitterand Instagram.

For media inquiries onlyplease contact [email protected]

SOURCE The Leukemia & Lymphoma Society (LLS)

#Leukemia #Lymphoma #Society #Named #Fast #Companys #Annual #Brands #Matter #List

Leave a Comment

Your email address will not be published. Required fields are marked *